Perrine Janiaud

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 14

Top Venues

Journal of neurology

Trials

F1000Research

Archives of disease in childhood

Stanford University

Université Claude Bernard Lyon 1 (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Stanford University

United States

Postdoctorate Fellow :: METRICS

Education History

Université Claude Bernard Lyon 1

France

PHD :: LBBE - UMR5558 - EMET team

Université Claude Bernard Lyon 1

France

MSC

Publications

Julian Hirt, Kinga Dembowska, Tim Woelfle, Cathrine Axfors, Cristina Granziera, Jens Kuhle, Ludwig Kappos, Lars G Hemkens, Perrine Janiaud
Clinical trial evidence of quality-of-life effects of disease-modifying therapies for multiple sclerosis: a systematic analysis. Journal of neurology 271 (6) (2024)
Julian Hirt, Kinga Dembowska, Tim Woelfle, Cathrine Axfors, Cristina Granziera, Jens Kuhle, Ludwig Kappos, Lars G Hemkens, Perrine Janiaud
Clinical trial evidence of quality-of-life effects of disease-modifying therapies for multiple sclerosis: a systematic analysis. Journal of neurology (2024)
Julian Hirt, Kinga Dembowska, Tim Woelfle, Cathrine Axfors, Cristina Granziera, Jens Kuhle, Ludwig Kappos, Lars G Hemkens, Perrine Janiaud
Clinical trial evidence of quality-of-life effects of disease-modifying therapies for multiple sclerosis: a systematic analysis. Journal of neurology 271 (6) (2024)
Julian Hirt, Kinga Dembowska, Tim Woelfle, Cathrine Axfors, Cristina Granziera, Jens Kuhle, Ludwig Kappos, Lars G Hemkens, Perrine Janiaud
Clinical trial evidence of quality-of-life effects of disease-modifying therapies for multiple sclerosis: a systematic analysis. Journal of neurology (2024)
Julian Hirt, Kinga Dembowska, Tim Woelfle, Cathrine Axfors, Cristina Granziera, Jens Kuhle, Ludwig Kappos, Lars G Hemkens, Perrine Janiaud
Clinical trial evidence of quality-of-life effects of disease-modifying therapies for multiple sclerosis: a systematic analysis. Journal of neurology 271 (6) (2024)
Julian Hirt, Kinga Dembowska, Tim Woelfle, Cathrine Axfors, Cristina Granziera, Jens Kuhle, Ludwig Kappos, Lars G Hemkens, Perrine Janiaud
Clinical trial evidence of quality-of-life effects of disease-modifying therapies for multiple sclerosis: a systematic analysis. Journal of neurology 271 (6) (2024)
Julian Hirt, Perrine Janiaud, Pascal Düblin, Lars G Hemkens
Meta-research on pragmatism of randomized trials: rationale and design of the PragMeta database. Trials 24 (1) (2023)
Julian Hirt, Perrine Janiaud, Pascal Düblin, Lars G Hemkens
Meta-research on pragmatism of randomized trials: rationale and design of the PragMeta database. Trials 24 (1) (2023)
Julian Hirt, Perrine Janiaud, Pascal Düblin, Lars G Hemkens
Meta-research on pragmatism of randomized trials: rationale and design of the PragMeta database. Trials 24 (1) (2023)
Julian Hirt, Perrine Janiaud, Lars G Hemkens
Randomized trials on non-pharmaceutical interventions for COVID-19: a scoping review. BMJ evidence-based medicine 27 (6) (2022)
Julian Hirt, Perrine Janiaud, Viktoria Luise Gloy, Stefan Schandelmaier, Tiago V Pereira, Despina Contopoulos-Ioannidis, Steven N Goodman, John P A Ioannidis, Klaus Munkholm, Lars G Hemkens
Robustness of reported postacute health outcomes in children with SARS-CoV-2 infection: a systematic review. Archives of disease in childhood (2022)
Perrine Janiaud, Telba Irony, Estelle Russek-Cohen, Steven N Goodman
U.S. Food and Drug Administration Reasoning in Approval Decisions When Efficacy Evidence Is Borderline, 2013-2018. Annals of internal medicine 174 (11) (2021)
Perrine Janiaud, Cathrine Axfors, Janneke Van't Hooft, Ramon Saccilotto, Arnav Agarwal, Christian Appenzeller-Herzog, Despina G Contopoulos-Ioannidis, Valentin Danchev, Ulrich Dirnagl, Hannah Ewald, Gerald Gartlehner, Steven N Goodman, Noah A Haber, Angeliki Diotima Ioannidis, John P A Ioannidis, Mark P Lythgoe, Wenyan Ma, Malcolm Macleod, Mario Malički, Joerg J Meerpohl, Yan Min, David Moher, Blin Nagavci, Florian Naudet, Christiane Pauli-Magnus, Jack W O'Sullivan, Nico Riedel, Jan A Roth, Mandy Sauermann, Stefan Schandelmaier, Andreas M Schmitt, Benjamin Speich, Paula R Williamson, Lars G Hemkens
The worldwide clinical trial research response to the COVID-19 pandemic - the first 100 days. F1000Research 9 (2020)
Perrine Janiaud, Cathrine Axfors, Janneke Van't Hooft, Ramon Saccilotto, Arnav Agarwal, Christian Appenzeller-Herzog, Despina G Contopoulos-Ioannidis, Valentin Danchev, Ulrich Dirnagl, Hannah Ewald, Gerald Gartlehner, Steven N Goodman, Noah A Haber, Angeliki Diotima Ioannidis, John P A Ioannidis, Mark P Lythgoe, Wenyan Ma, Malcolm Macleod, Mario Malički, Joerg J Meerpohl, Yan Min, David Moher, Blin Nagavci, Florian Naudet, Christiane Pauli-Magnus, Jack W O'Sullivan, Nico Riedel, Jan A Roth, Mandy Sauermann, Stefan Schandelmaier, Andreas M Schmitt, Benjamin Speich, Paula R Williamson, Lars G Hemkens
The worldwide clinical trial research response to the COVID-19 pandemic - the first 100 days. F1000Research (2020)

Perrine Janiaud.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Perrine Janiaud